!Curated data is available only for Italy. We will expand based on subscribers' requests
← Back to all funds

Renaissance Partners

Submit feedback

Website

Address

Milan
Private EquityIndustrialHealthcareTechnologyConsumer & RetailEnergy & EnvironmentFood & AgricultureMedia & Education

Established through the spin-off of Intesa Sanpaolo’s private equity activities, this firm specializes in scaling Italian 'champions' like Bending Spoons and U-Power through international buyouts.

€2.8B

AUM

3

Funds

14

Executives

Investment Profile

Investment Range

From €40M

Focus

Buy Out

Geographies

Italy

Assets (34 of 35)

10
Industrial Manufacturing
5
Healthcare
3
Technology
2
Consumer Goods
2
Fashion & Luxury
2
Specialized Industrials
1
Aerospace & Defense
9
Other
AssetStatusSectorHQSourceEntry Date
Alfasigma Group
CurrentHealthcareBolognaWebsite-
Arbo
CurrentIndustrial ManufacturingFanoWebsite-
Atos
CurrentIndustrial ManufacturingSesto CalendeWebsite-
CurrentTechnologyMilanWebsite-
Camfin Pirelli
CurrentAutomotiveMilanWebsite-
Cattleya
CurrentMedia & EntertainmentRomeWebsite-
Comelz
CurrentSpecialized IndustrialsVigevano (Pavia)Website-
Engineering
CurrentTechnologyRomeWebsite-
Farnese Vini
CurrentFood & BeverageOrtonaWebsite-
Fila
CurrentConsumer GoodsPeroWebsite-
Genetic
CurrentHealthcareFisciano (Salerno)Website-
Giochi Preziosi
CurrentConsumer GoodsCogliateWebsite-

Showing 112 of 34 assets

Page 1 of 3

People Analyticsn=25

Signals (4)

Investment
2026-03-30

U-Power Group secured a larger capex facility from lending banks to fund its acquisition of Cerva Group

Debt
2026-01-23

Uteco Converting receives refinancing and capital increase from Cherry Bank and Muzinich & Co.; Muzinich subscribes to capital increase with Renaissance Partners

Source: BeBeez
Investment
2025-10-01

Arbo announced the acquisition of 100% of Distribuciones Suner

Source: Arbo

Get these signals delivered weekly

Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.

Get Signals
Portfolio
2025-06-27

Neopharmed Gentili signed an agreement to acquire Bio Cryst's ORLADEYO business in Europe for up to $264M, including $250M upfront and milestone payments

Source: BioCryst

Showing 14 of 4 signals